How has been the historical performance of Indoco Remedies?

Answer:The historical performance of Indoco Remedies shows significant fluctuations in key financial metrics over the years.

Breakdown:
Indoco Remedies' net sales peaked at 1,817.29 Cr in Mar'24 but declined to 1,664.92 Cr in Mar'25. The total operating income followed a similar trend, decreasing from 1,817.29 Cr in Mar'24 to 1,664.92 Cr in Mar'25. Raw material costs were 396.27 Cr in Mar'25, down from 485.01 Cr in Mar'24, while employee costs increased to 394.05 Cr in Mar'25 from 361.93 Cr in the previous year. The total expenditure slightly decreased from 1,572.98 Cr in Mar'24 to 1,565.66 Cr in Mar'25. Operating profit (PBDIT) saw a sharp decline from 254.16 Cr in Mar'24 to 104.71 Cr in Mar'25, leading to a profit before tax of -74.37 Cr in Mar'25, compared to a profit of 135.80 Cr in Mar'24. Consequently, the profit after tax turned negative at -77.95 Cr in Mar'25, down from 97.01 Cr in Mar'24. The company's total assets increased from 1,658.20 Cr in Mar'23 to 2,144.73 Cr in Mar'24, while total liabilities also rose from 1,658.20 Cr to 2,144.73 Cr in the same period. Cash flow from operating activities was 156.00 Cr in Mar'24, down from 178.00 Cr in Mar'23, and the net cash inflow was minimal at 3.00 Cr in Mar'24. Overall, the data reflects a challenging year for Indoco Remedies in Mar'25, marked by declining sales and profitability despite an increase in total assets and liabilities.